- Hydrolyzed/renal diets testing specially selected proteins or hydrolyzed protein to improve digestibility and reduce progression risk. Cornell University
- Probiotic trials studying micro biome effects on renal markers and phosphorus metabolism. Michigan State University
- Oral adsorbent (Porus One) trial aiming to remove gut-derived toxins to improve CKD outcomes. Texas A&M University
- Registrations closed. Looks like they're in process now. Not finding any publications.
- Drug trials (sirolimus/Felycin CA-1) targeting aging/fibrosis to slow CKD progression. The Ohio State University
Last edited: